Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae

S Shi, M Xu, Y Zhao, L Feng, Q Liu, Z Yao… - ACS Infectious …, 2023 - ACS Publications
The goal of this study was to clarify the synergistic antibacterial activity of the combination of
tigecycline (TGC) and rifampicin (RIF). Additionally, the study sought to investigate the …
被引用次数：1 相关文章

Tigecycline-Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae.

S Shi, M Xu, Y Zhao, L Feng, Q Liu, Z Yao… - ACS Infectious …, 2023 - europepmc.org
The goal of this study was to clarify the synergistic antibacterial activity of the combination of
tigecycline (TGC) and rifampicin (RIF). Additionally, the study sought to investigate the …

Tigecycline-Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae

S Shi, M Xu, Y Zhao, L Feng, Q Liu… - ACS infectious …, 2023 - pubmed.ncbi.nlm.nih.gov
The goal of this study was to clarify the synergistic antibacterial activity of the combination of
tigecycline (TGC) and rifampicin (RIF). Additionally, the study sought to investigate the …